27 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 27 of 27 clinical reviews.
Can you take rapamycin (sirolimus) with acetaminophen? A guide covering CYP metabolism overlap, hepatotoxicity risk, monitoring protocols, and dose-adjustment strategies.
A detailed clinical review of the rapamycin (sirolimus) and apixaban drug interaction, covering CYP3A4/P-gp mechanisms, bleeding risk, monitoring protocols, and dose-adjustment guidance.
Sirolimus and atorvastatin share CYP3A4 metabolism, raising the risk of toxicity from both drugs. Learn the mechanism, severity, monitoring labs, and dose-adjustment strategies.
A clinician-level review of the pharmacokinetic and pharmacodynamic interaction between sirolimus (rapamycin) and benzodiazepines, covering CYP3A4/P-gp mechanisms, severity classification, monitoring protocols, dose-adjustment strategies, and patient counseling.
Clinical review of the rapamycin (sirolimus) and bupropion drug interaction, covering CYP enzyme mechanisms, severity rating, dose adjustments, monitoring parameters, and patient counseling.
A complete clinical guide to the rapamycin-caffeine interaction: pharmacokinetics, CYP3A4 and mTOR pathway overlap, safety data, and practical dosing guidance prepared by the HealthRX.com Editorial Team.
A breakdown of the rapamycin, cannabis drug interaction, covering CYP3A4 and P-gp pharmacokinetics, immunosuppression risks, cannabinoid-specific data, and practical dosing guidance.
Clinical guide to the rapamycin (sirolimus) and clopidogrel drug interaction, covering CYP3A4 competition, P-glycoprotein overlap, severity grading, dose adjustment, and monitoring protocols.
Can you take rapamycin (sirolimus) with diphenhydramine? A guide covering CYP3A4 metabolism, CNS and anticholinergic overlap, monitoring parameters, and dose-adjustment strategies.
A detailed clinical review of the sirolimus, gabapentin drug interaction: mechanism, severity, monitoring parameters, dose-adjustment guidance, and patient counseling based on FDA labels and primary literature.
A guide to the CYP3A4-based drug interaction between sirolimus (rapamycin) and hormonal contraceptives, covering mechanism, severity, monitoring, dose adjustment, and patient counseling.
A guide to the sirolimus, contrast dye interaction, covering nephrotoxicity risk, iodinated and gadolinium agents, hold protocols, and what to discuss with your prescriber before any imaging procedure.
Clinical guide to the rapamycin (sirolimus) and levothyroxine drug interaction, including mechanism, severity, monitoring considerations, and what remains unverified.
Can you take rapamycin (sirolimus) with metformin? A guide covering the pharmacokinetic and pharmacodynamic interaction, monitoring protocols, dose adjustments, and real-world clinical evidence.
Clinical guide to the rapamycin (sirolimus) and NSAID interaction. Covers renal risk, GI bleeding, pharmacokinetic overlap, monitoring labs, and dose-adjustment strategies.
A clinician-level review of the sirolimus, opioid drug interaction, covering CYP3A4/P-gp mechanisms, severity ratings, monitoring parameters, dose-adjustment guidance, and patient counseling for oxycodone, hydrocodone, and tramadol.
Clinical guide to the rapamycin (sirolimus) and PPI interaction. Covers CYP3A4/P-gp mechanisms, omeprazole vs. pantoprazole differences, monitoring, and dose adjustment.
A clinician-level review of the pharmacokinetic and pharmacodynamic interaction between sirolimus (rapamycin) and progesterone HRT, including CYP3A4/P-gp mechanisms, monitoring principles, and what remains unverified.
Clinical guide to the sirolimus-rivaroxaban drug interaction. Covers CYP3A4 and P-glycoprotein overlap, bleeding and toxicity risks, monitoring protocols, and dose-adjustment strategies reviewed by physicians.
A guide to the drug interaction between rapamycin (sirolimus) and rosuvastatin, covering pharmacokinetic mechanisms, muscle toxicity risk, monitoring protocols, and dose adjustments.
A clinical review of the rapamycin (sirolimus) and sildenafil drug interaction, covering CYP3A4 metabolism, blood level changes, dose adjustment, monitoring, and safety considerations.
Clinical guide to the sirolimus-simvastatin drug interaction. Covers CYP3A4 mechanism, rhabdomyolysis risk, dose limits, monitoring protocols, and statin alternatives for patients on rapamycin.
A detailed clinical guide to the rapamycin (sirolimus) and tadalafil drug interaction, covering CYP3A4 metabolism, dose adjustments, monitoring parameters, and patient counseling.
What is established, what is plausible, and what remains unproven about combining sirolimus (Rapamune) with testosterone replacement therapy, including CYP3A4 overlap, erythrocytosis risk, and a monitoring framework.
A cautious clinical review of the pharmacokinetic and pharmacodynamic interaction between sirolimus (rapamycin, Rapamune) and trazodone, covering CYP3A4/P-glycoprotein mechanism, what is established versus plausible, monitoring approach, and alternatives, with an evidence-status assessment for clinicians and pharmacists.
A deep dive into the sirolimus, warfarin drug interaction: CYP3A4/P-gp mechanism, INR monitoring, dose adjustment, and patient counseling backed by primary literature and FDA labeling.
Can you take rapamycin (sirolimus) with zolpidem? A guide covering the CYP3A4 interaction mechanism, severity rating, dose adjustment, monitoring, and patient counseling.